SOUMYA ALEX: Open Payments
NPI 1164970950 · BENSALEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,222 in 47 payments from 17 companies in 2025. Trend: 2023 $1,282 · 2024 $1,587 · 2025 $1,222
Food & beverage: $1,203Education: $19
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $220 |
| Novo Nordisk Inc | 11 | $184 |
| SANOFI-AVENTIS U.S. LLC | 4 | $164 |
| Lilly USA, LLC | 2 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $97 |
| Amgen Inc. | 4 | $63 |
| Lundbeck LLC | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Abbott Laboratories | 2 | $44 |
| Corcept Therapeutics | 1 | $36 |
Products named: TZIELD, BREZTRI, KISUNLA, REXULTI, CAPLYTA, AIRSUPRA, FREESTYLE LIBRE 3, Korlym.
Industry payments across PA — which companies pay providers there.
